Table 5.
Relapse | ||||||
---|---|---|---|---|---|---|
95% CI | 95% CI | Overall | ||||
CIBMTR MDS score | N | RR | Lower Limit | Upper Limit | p-value | p-value |
Low | 19 | 1 | 0.3072 | |||
Intermediate | 83 | 0.749 | 0.281 | 1.997 | 0.5631 | |
High/Very high | 44 | 0.869 | 0.304 | 2.486 | 0.7932 | |
Missing | 34 | 1.378 | 0.499 | 3.805 | 0.5366 | |
Conditioning regimen | ||||||
Myeloablative | 62 | 1 | 0.0008 | |||
RIC/NMA | 118 | 3.963 | 1.775 | 8.85 | 0.0008 | |
TRM | ||||||
95% CI | 95% CI | Overall | ||||
CIBMTR MDS score [23] | N | RR | Lower Limit | Upper Limit | p-value | p-value |
Low | 19 | 1 | 0.7711 | |||
Intermediate | 83 | 0.752 | 0.32 | 1.768 | 0.5131 | |
High/Very high | 44 | 1.044 | 0.463 | 2.352 | 0.9177 | |
Missing | 34 | 0.802 | 0.318 | 2.02 | 0.6397 | |
HCT-CI | ||||||
0 | 58 | 1 | 0.0225 | |||
1–2 | 50 | 1.085 | 0.611 | 1.928 | 0.781 | |
≥3 | 61 | 2.132 | 1.249 | 3.638 | 0.0055 | |
Missing | 11 | 0.963 | 0.418 | 2.22 | 0.9301 | |
DFS | ||||||
95% CI | 95% CI | Overall | ||||
CIBMTR MDS score | N | RR | Lower Limit | Upper Limit | p-value | p-value |
Low | 19 | 1 | 0.3668 | |||
Intermediate | 83 | 0.845 | 0.401 | 1.782 | 0.6591 | |
High/Very high | 44 | 1.058 | 0.535 | 2.092 | 0.8706 | |
Missing | 34 | 1.212 | 0.595 | 2.468 | 0.5968 | |
HCT-CI | ||||||
0 | 58 | 1 | 0.0308 | |||
1–2 | 50 | 1.093 | 0.64 | 1.865 | 0.7454 | |
≥3 | 61 | 1.877 | 1.115 | 3.161 | 0.0178 | |
Missing | 11 | 1.336 | 0.809 | 2.206 | 0.2575 | |
OS | ||||||
95% CI | 95% CI | Overall | ||||
CIBMTR MDS score | N | RR | Lower Limit | Upper Limit | p-value | p-value |
Low | 20 | 1 | 0.6573 | |||
Intermediate | 85 | 0.81 | 0.377 | 1.738 | 0.5881 | |
High/Very high | 44 | 1.062 | 0.507 | 2.227 | 0.8726 | |
Missing | 34 | 0.939 | 0.467 | 1.886 | 0.8589 | |
HCT-CI | ||||||
0 | 60 | 1 | 0.0016 | |||
1–2 | 50 | 1.064 | 0.591 | 1.915 | 0.8364 | |
≥3 | 61 | 2.084 | 1.228 | 3.537 | 0.0065 | |
Missing | 12 | 1.738 | 1.056 | 2.86 | 0.0295 |